Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HLTH Insider Trading

HLTH | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HLTH provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2024-08-28 03:07 2024-08-23 Tarsadia Capital, LLC 10% owner SELL $0.00 18,302,244 $1,830 0 -100.0%
2022-12-10 04:32 2022-12-08 Sever Clint Officer - Chief Product Officer OPT+S $3.02 29,269 $88,334 3,939,647 0.0%
2022-12-08 05:11 2022-12-06 Sever Clint Officer - Chief Product Officer OPT+S $3.06 50,811 $155,685 3,939,647 0.0%
2022-12-02 03:31 2022-11-30 Sever Clint Officer - Chief Product Officer OPT+S $3.11 22,725 $70,675 3,950,280 0.0%
2022-11-26 02:07 2022-11-22 Sever Clint Officer - Chief Product Officer OPT+S $2.54 57,267 $145,458 3,950,280 0.0%
2022-11-11 05:03 2022-11-08 Sever Clint Officer - Chief Product Officer OPT+S $3.83 79,992 $306,105 3,950,280 0.0%
2022-10-28 04:19 2022-10-25 Sever Clint Officer - Chief Product Officer OPT+S $3.61 79,992 $289,035 3,950,280 0.0%
2022-10-14 03:03 2022-10-11 Sever Clint Officer - Chief Product Officer OPT+S $3.29 79,992 $262,910 3,950,280 0.0%
2022-10-04 03:33 2022-09-30 Sever Clint Officer - Chief Product Officer OPT+S $3.03 7,374 $22,343 3,950,280 0.0%
2022-09-30 02:15 2022-09-27 Sever Clint Officer - Chief Product Officer OPT+S $3.00 72,618 $217,934 3,950,280 0.0%
2022-09-16 04:51 2022-09-13 Sever Clint Officer - Chief Product Officer OPT+S $3.63 79,992 $290,131 3,975,555 0.0%
2022-09-02 03:05 2022-08-30 Sever Clint Officer - Chief Product Officer OPT+S $3.34 79,992 $266,853 3,986,188 0.0%
2022-08-19 01:53 2022-08-16 Sever Clint Officer - Chief Product Officer OPT+S $4.25 79,992 $339,622 3,986,188 0.0%
2022-08-05 02:46 2022-08-02 Sever Clint Officer - Chief Product Officer OPT+S $3.54 79,992 $283,468 3,986,188 0.0%
2022-07-22 04:10 2022-07-19 Sever Clint Officer - Chief Product Officer OPT+S $3.40 79,992 $271,869 3,986,188 0.0%
2018-08-30 23:05 2018-08-08 Efird Kenneth Officer - President BUY $0.83 13,000 $10,790 610,400 +2.2%
2018-08-09 03:21 2018-08-06 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $0.85 50,000 $42,500 2,852,955 +1.8%
2018-08-09 03:17 2018-08-07 Efird Kenneth Officer - President BUY $0.88 60,000 $52,998 597,400 +11.2%
2017-05-27 00:35 2017-05-26 Young Paul David Officer - CFO BUY $1.40 10,000 $13,950 10,000 +100.0%
2017-03-24 00:23 2017-03-23 FLEMING HARRY JOSEPH Officer - Chief Executive Officer BUY $1.69 25,000 $42,250 2,802,955 +0.9%
2017-03-23 00:23 2017-03-21 FLEMING HARRY JOSEPH Officer - Chief Executive Officer BUY $1.75 25,000 $43,750 2,777,955 +0.9%
2017-03-21 01:03 2017-03-17 Rodriguez Marcos Alberto Officer - Chief Accounting Officer BUY $1.70 3,500 $5,950 3,500 +100.0%
2017-03-21 01:03 2017-03-17 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $1.70 25,000 $42,500 2,752,955 +0.9%
2016-12-21 02:21 2016-12-20 HORAN PETER Director BUY $1.90 5,000 $9,500 5,000 +100.0%
2016-12-21 02:21 2016-12-20 NICHOLS MICHAEL C Director BUY $1.87 10,000 $18,700 10,000 +100.0%
2016-03-11 03:27 2016-02-18 Kramer Donald Louis 10% owner BUY $2.30 20,000 $46,046 15,874,482 +0.1%
2016-03-11 03:24 2016-02-17 Kramer Donald Louis 10% owner BUY $2.19 20,000 $43,824 15,854,482 +0.1%
2016-03-11 02:55 2015-05-13 Kramer Donald Louis 10% owner SELL $4.50 1,350,000 $6,075,000 15,794,482 -7.9%
2016-02-18 23:31 2016-02-16 Kramer Donald Louis 10% owner BUY $2.08 20,000 $41,560 15,834,482 +0.1%
2016-02-17 21:38 2016-02-12 Kramer Donald Louis 10% owner BUY $1.97 20,000 $39,422 15,814,482 +0.1%
2016-02-05 18:54 2016-02-04 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $2.38 10,000 $23,794 2,727,955 +0.4%
2016-02-03 19:24 2016-02-03 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $2.22 10,000 $22,170 2,717,955 +0.4%
2016-02-03 00:00 2016-01-29 Efird Kenneth Officer - EVP/Chief Operating Officer BUY $2.08 11,900 $24,701 537,400 +2.3%
2016-02-02 21:58 2016-02-01 KLEIN KENNETH JOSEPH Officer - Chief Financial Officer BUY $2.16 5,000 $10,800 5,000 +100.0%
2016-02-02 21:35 2016-02-02 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $2.20 10,000 $21,951 2,707,955 +0.4%
2016-02-01 22:47 2016-01-29 MARUCA MATTHEW KEAVNEY Officer, Other - General Counsel BUY $2.07 2,300 $4,761 2,300 +100.0%
2016-02-01 22:45 2016-01-29 FLEMING HARRY JOSEPH Director, Officer - Chief Executive Officer BUY $1.99 31,700 $62,956 5,000 +100.0%
2016-02-01 20:08 2016-01-29 HAUSER JENNIFER Director BUY $1.97 9,137 $18,000 15,746 +138.3%
2016-01-29 01:05 2016-01-26 HAUSER JENNIFER Director BUY $2.06 8,700 $17,922 15,309 +131.6%
2016-01-23 01:38 2016-01-22 GANLEY RICHARD Director BUY $2.11 10,000 $21,090 68,550 +17.1%
2015-09-11 21:21 2015-09-11 GANLEY RICHARD Director BUY $4.50 5,000 $22,500 58,550 +9.3%
2015-08-25 02:04 2015-08-21 GANLEY RICHARD Director BUY $4.66 5,300 $24,683 53,550 +11.0%
2015-06-19 01:52 2015-06-18 GANLEY RICHARD Director BUY $6.58 6,000 $39,461 48,250 +14.2%
2008-11-26 19:58 2008-11-25 MIDGETTE WILLIAM G Officer - CEO, Porex Corporation SELL $8.47 13,500 $114,332 11 -99.9%
2008-11-25 00:55 2008-11-24 Cameron Kevin M Director SELL $8.33 100,000 $833,470 501,028 -16.6%
2008-11-24 23:17 2008-11-24 GATTINELLA WAYNE T Officer - CEO & President, WebMD Health OPT+S $8.40 35,000 $293,878 8,630 0.0%
2008-11-24 22:09 2008-11-21 GATTINELLA WAYNE T Officer - CEO & President, WebMD Health SELL $8.16 11,588 $94,538 8,630 -57.3%
2008-11-24 19:35 2008-11-21 BROOKE PAUL A Director SELL $8.07 100,000 $806,770 70,000 -58.8%
2008-05-28 23:56 2008-05-27 SARKOWSKY HERMAN Director OPT+S $11.41 25,000 $285,298 495,996 0.0%
2006-12-05 21:35 2006-12-04 WYGOD MARTIN J Director, Officer - Chariman of the Board SELL $12.00 500,000 $6,000,000 7,492,071 -6.3%
SHOW ENTRIES
1-50 OF 90

How to Interpret $HLTH Trades

Not every insider transaction in HLTH is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HLTH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HLTH

Insider activity data for HLTH is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HLTH, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.